A body of data disclose the causal role of IGF2BP2 in cancer etiology, and find that IGF2BP2 is overexpressed during carcinogenesis and early development, which causes the tumorigenic phenotype, tumor progression and unfavorable prognosis [73]. The gene discussed is IGF2BP2; the disease is cancer.